Dimensional Fund Advisors LP Sarepta Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 803,888 shares of SRPT stock, worth $17.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

803,888

Previous 586,318 37.11%

Holding current value

$17.8 Million

Previous $37.4 Million 63.26%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$17.1 - $63.66 $3.72 Million - $13.9 Million	217,570 Added 37.11%	803,888 $13.7 Million
Q1 2025 May 13, 2025	BUY	$63.82 - $127.89 $17.6 Million - $35.2 Million	275,508 Added 88.64%	586,318 $37.4 Million
Q4 2024 Feb 13, 2025	BUY	$104.54 - $137.94 $3.2 Million - $4.22 Million	30,615 Added 10.93%	310,810 $37.8 Million
Q3 2024 Nov 07, 2024	BUY	$124.33 - $156.75 $3.08 Million - $3.89 Million	24,799 Added 9.71%	280,195 $35 Million
Q2 2024 Aug 09, 2024	BUY	$113.33 - $163.85 $3.53 Million - $5.1 Million	31,105 Added 13.87%	255,396 $40.4 Million
Q1 2024 May 10, 2024	BUY	$93.7 - $141.53 $8,433 - $12,737	90 Added 0.04%	224,291 $29 Million
Q4 2023 Feb 07, 2024	BUY	$67.31 - $124.76 $1.41 Million - $2.61 Million	20,923 Added 10.29%	224,201 $21.6 Million
Q3 2023 Nov 09, 2023	BUY	$102.5 - $123.59 $2.1 Million - $2.54 Million	20,516 Added 11.23%	203,278 $24.6 Million
Q2 2023 Aug 09, 2023	SELL	$106.4 - $157.19 $725,967 - $1.07 Million	-6,823 Reduced 3.6%	182,762 $20.9 Million
Q1 2023 May 12, 2023	SELL	$117.53 - $155.99 $386,086 - $512,427	-3,285 Reduced 1.7%	189,585 $26.1 Million
Q4 2022 Feb 09, 2023	BUY	$100.86 - $132.13 $381,654 - $499,979	3,784 Added 2.0%	192,870 $25 Million
Q3 2022 Nov 10, 2022	BUY	$75.71 - $119.24 $2.08 Million - $3.28 Million	27,496 Added 17.02%	189,086 $20.9 Million
Q2 2022 Aug 12, 2022	SELL	$62.69 - $88.44 $1.11 Million - $1.57 Million	-17,704 Reduced 9.87%	161,590 $12.1 Million
Q1 2022 May 13, 2022	BUY	$63.15 - $90.42 $1.24 Million - $1.78 Million	19,660 Added 12.32%	179,294 $14 Million
Q4 2021 Feb 09, 2022	SELL	$77.28 - $99.42 $604,561 - $777,762	-7,823 Reduced 4.67%	159,634 $14.4 Million
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $358,876 - $503,091	5,440 Added 3.36%	167,457 $15.5 Million
Q2 2021 Aug 12, 2021	SELL	$69.38 - $86.75 $995,256 - $1.24 Million	-14,345 Reduced 8.13%	162,017 $12.6 Million
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $1.17 Million - $2.73 Million	-16,147 Reduced 8.39%	176,362 $13.2 Million
Q4 2020 Feb 25, 2021	BUY	$125.56 - $178.74 $24.2 Million - $34.4 Million	192,509 New	192,509 $32.8 Million

Others Institutions Holding SRPT

# of Institutions

462

Shares Held

82.5M

Call Options Held

5.6M

Put Options Held

4.19M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.94B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Sarepta Therapeutics, Inc. Transaction History